Christiane Querfeld
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Chicago
Illinois 60611
USA
Name/email consistency: high
- Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy. Querfeld, C., Kuzel, T.M., Guitart, J., Rosen, S.T. Oncology (Williston Park, N.Y.) (2007)
- Bexarotene in the treatment of cutaneous T-cell lymphoma. Querfeld, C., Nagelli, L.V., Rosen, S.T., Kuzel, T.M., Guitart, J. Expert. Opin. Pharmacother (2006)
- The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway. Querfeld, C., Rizvi, M.A., Kuzel, T.M., Guitart, J., Rademaker, A., Sabharwal, S.S., Krett, N.L., Rosen, S.T. J. Invest. Dermatol. (2006)
- Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches. Querfeld, C., Rosen, S.T., Kuzel, T.M., Guitart, J. Semin. Cutan. Med. Surg (2003)









